The Best Christmas Gifts for 2014

Want to know what’s hot for Christmas this year?

We’ve got the rundown on the best Christmas gifts for 2014, the most popular gift ideas for kids, women, and that man in your life. 

Which toys will be the favor with the kids this coming Christmas?

We have the “best toys for 2014″ list, the hottest toys, electronics, tech, shoes and “must haves” are all here, and we will update our websites daily. 

1. Toys (Transformers Generations Leader Class Jetfire Figure)
2. Electronics (ASUS CHROMEBOX-M004U Desktop)
3. Tech (Transcend 64GB MicroSDXC Class10 UHS-1 Memory Card with Adapter 45 MB/s (TS64GUSDU1E)
4. Smart Phone (New 22400mAh Portable Ultra-high Density External Battery Pack Backup Charger For iPhone 5S 5C 5)
5. Shoes (EMU Australia Alba Mini Mini Boot (Toddler/Little Kid/Big Kid)
6. Jewelry (Austrian Crystal Eternal Love Teardrop 100% Genuine Swarovski Elements with Swarovski Cubic Zirconia Crystal Adorable Genuine 18k White Gold Plated Pendant Necklace Fashion Jewelry Gift for Mom for Girls for Women for Teens -Ocean Blue)

Also check out, the top selling Christmas gifts website.  

It's going to be BIG!

Let just tell you right now, PPHM is going to sky rocket!  Have you read the latest news?

Peregrine Pharmaceuticals Receives FDA Fast Track Designation for Its Immunotherapy Bavituximab as a Potential Treatment of Second-Line Non-Small Cell Lung Cancer

This companies stock is going to reach new heights.   Well, at least it looks good on paper. 

About PPHM

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative monoclonal antibodies in clinical trials focused on the treatment and diagnosis of cancer. We are pursuing multiple clinical programs in cancer with our lead product candidate bavituximab and novel brain cancer agent Cotara®. Peregrine also has in-house cGMP manufacturing capabilities through its wholly-owned subsidiary Avid Bioservices, Inc. (www.avidbio.com), which provides development and biomanufacturing services for both Peregrine and outside customers.

For oncology indications, our lead PS-targeting candidate bavituximab in combination with chemotherapy has demonstrated promising signs of anti-tumor activitiy and survival trends in patients with non-small cell lung cancer (NSCLC) and advanced breast cancer.